Specialty drug counterfeiting - global view

Why cold chain matters for specialty drugs

Most specialty biologics, cell therapies, gene therapies, and many injectable small molecules require storage within tight temperature ranges — commonly refrigerated (2-8°C), sometimes frozen (−20°C), and in some cases cryogenic (−70°C or lower). A single excursion outside that range can denature a biologic, compromise potency, or void the product entirely. For a cross-border specialty shipment, the cold chain is not a logistics nicety; it is part of the clinical product.

What “good” looks like

A well-run specialty cold chain has four elements. Packaging qualification: the shipper, gel packs or phase-change material, and dwell time are validated for the expected transit and a realistic worst case. Continuous temperature monitoring: a calibrated logger travels with the shipment and records temperature at a documented interval. Chain-of-custody documentation: every transfer point is logged, with time, temperature read, and handler identity. Excursion protocol: any out-of-range event triggers a defined review, and the product is quarantined until a qualified pharmacist releases it or rejects it.

What can go wrong

Typical failure modes include packaging that is qualified for the route but not the actual season, customs holds that extend transit beyond dwell time, carrier handoffs where the logger is not continuous, and receiving-site handling that leaves the product on a desk rather than in a qualified fridge. Most of these failures are preventable with planning; a few are only detectable after the fact via logger data.

Receipt at the treating site

When the shipment arrives at the treating physician or hospital pharmacy, the receiver should download the logger data before opening the package, confirm the temperature record against the acceptance range, inspect the product and secondary packaging visually, and sign the DSCSA transaction documentation. If the logger shows any excursion, the product should be quarantined and the sourcing partner notified immediately — do not dispense or administer.

What Reserve Meds does

For every cold-chain shipment, we use qualified specialty-pharmacy packaging, attach a continuous-read logger, ship via a specialty carrier lane, and send the logger data and DSCSA documentation to the receiver ahead of arrival. If an excursion is detected, we replace the product at our cost under our quality SOPs — the patient should not carry the risk of a supply-chain failure.

Further reading

See our cold-chain basics explainer for the physics and our serialization and chain-of-custody explainer for the documentation side.

Start a request

Start a request